TY - JOUR
T1 - PILRα binds an unknown receptor expressed primarily on CD56bright and decidual-NK cells and activates NK cell functions
AU - Ophir, Yael
AU - Duev-Cohen, Alexandra
AU - Yamin, Rachel
AU - Tsukerman, Pini
AU - Bauman, Yoav
AU - Gamliel, Moriya
AU - Mandelboim, Ofer
PY - 2016/7/5
Y1 - 2016/7/5
N2 - Natural Killer (NK) cells are innate immune lymphocytes specializing in recognition and killing of tumors and pathogens, using an array of activating and inhibitory receptors. NK inhibition is mediated by a large repertoire of inhibitory receptors, whereas a limited number of activating NK cell receptors execute NK cell activation. The ligands recognized by the activating receptors are stress-induced, pathogen derived, tumor specific and even self ligands. However, the full spectrum of NK cell receptors and ligands that control NK cell activity remains uncharacterized. Here we demonstrate that Paired Ig-Like type 2 Receptor Alpha (PILRα), binds a distinct human NK cell sub-population present in the peripheral blood and also in the decidua. We further demonstrate that the interaction of NK cells with PILRα expressing targets lead to elevated IFNγ secretion and cytotoxicity. In conclusion, we present here a novel NK activating ligand which binds and activates an unknown NK receptor expressed on a unique NK cell subset.
AB - Natural Killer (NK) cells are innate immune lymphocytes specializing in recognition and killing of tumors and pathogens, using an array of activating and inhibitory receptors. NK inhibition is mediated by a large repertoire of inhibitory receptors, whereas a limited number of activating NK cell receptors execute NK cell activation. The ligands recognized by the activating receptors are stress-induced, pathogen derived, tumor specific and even self ligands. However, the full spectrum of NK cell receptors and ligands that control NK cell activity remains uncharacterized. Here we demonstrate that Paired Ig-Like type 2 Receptor Alpha (PILRα), binds a distinct human NK cell sub-population present in the peripheral blood and also in the decidua. We further demonstrate that the interaction of NK cells with PILRα expressing targets lead to elevated IFNγ secretion and cytotoxicity. In conclusion, we present here a novel NK activating ligand which binds and activates an unknown NK receptor expressed on a unique NK cell subset.
KW - CD56 bright
KW - Immune response
KW - Immunity
KW - Immunology and Microbiology Section
KW - NK
KW - PILRa
UR - http://www.scopus.com/inward/record.url?scp=85018388403&partnerID=8YFLogxK
U2 - 10.18632/oncotarget.8397
DO - 10.18632/oncotarget.8397
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 27029068
AN - SCOPUS:85018388403
SN - 1949-2553
VL - 7
SP - 40953
EP - 40964
JO - Oncotarget
JF - Oncotarget
IS - 27
ER -